TELA Bio Q2 Revenue Falls 4%, Going Concern Warning Issued as Covenant Breach Looms
TELA sits 58% above its 52-week low of $0.501 on elevated volume (2.0× avg).
Summary
TELA Bio reported a 4% revenue decline and a wider net loss for Q2 2026, and warned it will likely breach its debt covenant, raising substantial doubt about its ability to continue as a going concern.
Key Events · Earnings and Guidance · TELA
-
Going Concern Warning
Management concluded substantial doubt exists about the company's ability to continue as a going concern, as it is probable it will breach the minimum revenue covenant under its $60M Perceptive Credit Agreement within the next twelve months.
-
Revenue Decline
Q2 2026 revenue fell 4% year-over-year to $19.3 million, driven by a 23% drop in OviTex PRS unit sales, partially offset by a 12% increase in OviTex units.
-
Widening Losses
Net loss increased 13% to $11.3 million, with interest expense nearly doubling to $2.1 million due to the higher-cost Perceptive debt.
-
Cash Burn Accelerates
Cash used in operations was $20.6 million in H1 2026, reducing cash reserves to $30.4 million as of June 30, 2026, from $50.8 million at year-end 2025.
Analysis · TELA · Industrial Applications And Services
TELA Bio's Q2 2026 results confirm a deepening crisis. Revenue dropped 4% to $19.3 million, driven by a sharp decline in OviTex PRS sales, while the net loss widened to $11.3 million. More critically, management disclosed that it is probable the company will breach its minimum revenue covenant under the Perceptive Credit Agreement within the next twelve months, raising substantial doubt about its ability to continue as a going concern. With only $30.4 million in cash and a $60 million debt load, the company is now scrambling to negotiate a waiver or amendment with its lender. This filing comes just days after the new CEO withdrew full-year guidance, painting a dire picture of a company fighting for survival.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 41.9% of the 327 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.46%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TELA was trading at $0.79 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $35.4M. The 52-week trading range was $0.50 to $2.14. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.